TA-1801

• Description:

  TA-1801 is a hypolipidemic agent, the active form is TA-1901A[1][2].

• UNSPSC:

  12352005

• Target:

  Drug Intermediate

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/TA-1801.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OCC)CC1=C(C2=CC=CO2)OC(C3=CC=C(Cl)C=C3)=N1

• Molecular Formula:

  C17H14ClNO4

• Molecular Weight:

  331.75

• References & Citations:

  [1]Moriya T, et al. Synthesis of ethyl 2- (4-chlorophenyl) -5- (2-furyl) -4-oxazoleacetate, a hypolipidemic agent, and related compounds. J Med Chem. 1988 Jun;31 (6) :1197-204.|[2]Kaji H, et al. Glucuronidation of 2- (4-chlorophenyl) -5- (2-furyl) -4-oxazoleacetic acid (TA-1801A) in humans: species differences in liver and intestinal microsomes. Drug Metab Pharmacokinet. 2005 Jun;20 (3) :206-11.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [88352-44-7]